We are a world-leading basic and translational inflammatory sciences centre.
The three major themes of our research - immunity and microbiome, inflammation biology and tissue remodelling and repair - are relevant for a diverse range of chronic inflammatory disorders, including arthritis, inflammatory bowel disease, tissue fibrosis and certain types of cancer.
We apply state-of-the-art technologies in analysis of disease models and patient tissue samples to understand why disease develops and to reveal new diagnostic markers and targets for therapy.
Strategic partnerships with nearby clinical centres such as the Nuffield Orthopaedic Centre and the John Radcliffe Hospital facilitate scientific translation from bench to bedside.
OA centre
Our Arthritis Research UK Centre of Excellence aims to develop new treatments for arthritis, improving healthcare and transforming people's lives.
LATEST NEWS
-
A workshop for curing arthritis sooner
20 March 2018
-
Kennedy Institute Microbiome Symposium
6 March 2018
-
Research challenges use of off-label drug to treat osteoarthritis
21 February 2018
-
Kennedy Institute-DRFZ Workshop, Berlin
16 February 2018
-
Jacques Monod Prize for Kennedy honorary researcher
16 February 2018
Select Publications
-
Durable Interactions of T Cells with T Cell Receptor Stimuli in the Absence of a Stable Immunological Synapse.
Mayya V. et al, (2018), Cell Rep, 22, 340 - 349
-
B1a B cells require autophagy for metabolic homeostasis and self-renewal.
Clarke AJ. et al, (2018), J Exp Med, 215, 399 - 413
-
Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers.
Zuliani-Alvarez L. et al, (2017), Nat Commun, 8
-
A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages.
Danne C. et al, (2017), Cell Host Microbe, 22, 733 - 745.e5